Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,144 | -12,047 | -11,434 | -10,752 | -16,867 |
| Depreciation Amortization | 74 | 70 | 123 | 141 | 148 |
| Accounts receivable | N/A | N/A | 216 | -116 | -78 |
| Other Working Capital | 3,012 | 140 | 1,687 | -866 | -2,214 |
| Other Operating Activity | 862 | 350 | -15 | -187 | 1,186 |
| Operating Cash Flow | $-9,197 | $-11,487 | $-9,423 | $-11,780 | $-17,825 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 1,611 | -21 | -23 | -27 |
| PPE Investments | -83 | -82 | -18 | -85 | -138 |
| Investing Cash Flow | $-83 | $1,530 | $-39 | $-108 | $-166 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,862 | 7,996 | N/A | N/A | N/A |
| Other Financing Activity | 2,399 | 1,887 | 722 | 18,544 | 8,193 |
| Financing Cash Flow | $10,260 | $9,884 | $722 | $18,544 | $8,193 |
| Exchange Rate Effect | 457 | -79 | -309 | 1,072 | -229 |
| Beginning Cash Position | 9,132 | 9,283 | 18,137 | 11,089 | 22,847 |
| End Cash Position | 10,570 | 9,130 | 9,088 | 18,817 | 12,821 |
| Net Cash Flow | $1,438 | $-153 | $-9,049 | $7,728 | $-10,026 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,197 | -11,487 | -9,423 | -11,780 | -17,825 |
| Capital Expenditure | -83 | -82 | -18 | -85 | -138 |
| Free Cash Flow | -9,279 | -11,569 | -9,441 | -11,865 | -17,964 |